1. Home
  2. DXYZ vs TNYA Comparison

DXYZ vs TNYA Comparison

Compare DXYZ & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXYZ
  • TNYA
  • Stock Information
  • Founded
  • DXYZ N/A
  • TNYA 2016
  • Country
  • DXYZ
  • TNYA United States
  • Employees
  • DXYZ N/A
  • TNYA N/A
  • Industry
  • DXYZ
  • TNYA Medicinal Chemicals and Botanical Products
  • Sector
  • DXYZ
  • TNYA Health Care
  • Exchange
  • DXYZ Nasdaq
  • TNYA Nasdaq
  • Market Cap
  • DXYZ 313.1M
  • TNYA 326.0M
  • IPO Year
  • DXYZ 2024
  • TNYA 2021
  • Fundamental
  • Price
  • DXYZ $23.60
  • TNYA $1.73
  • Analyst Decision
  • DXYZ
  • TNYA Strong Buy
  • Analyst Count
  • DXYZ 0
  • TNYA 5
  • Target Price
  • DXYZ N/A
  • TNYA $8.60
  • AVG Volume (30 Days)
  • DXYZ N/A
  • TNYA 4.8M
  • Earning Date
  • DXYZ N/A
  • TNYA 11-06-2025
  • Dividend Yield
  • DXYZ N/A
  • TNYA N/A
  • EPS Growth
  • DXYZ N/A
  • TNYA N/A
  • EPS
  • DXYZ N/A
  • TNYA N/A
  • Revenue
  • DXYZ N/A
  • TNYA N/A
  • Revenue This Year
  • DXYZ N/A
  • TNYA N/A
  • Revenue Next Year
  • DXYZ N/A
  • TNYA N/A
  • P/E Ratio
  • DXYZ N/A
  • TNYA N/A
  • Revenue Growth
  • DXYZ N/A
  • TNYA N/A
  • 52 Week Low
  • DXYZ N/A
  • TNYA $0.36
  • 52 Week High
  • DXYZ N/A
  • TNYA $4.01
  • Technical
  • Relative Strength Index (RSI)
  • DXYZ 38.19
  • TNYA 51.51
  • Support Level
  • DXYZ $25.00
  • TNYA $1.77
  • Resistance Level
  • DXYZ $26.80
  • TNYA $2.02
  • Average True Range (ATR)
  • DXYZ 1.64
  • TNYA 0.17
  • MACD
  • DXYZ -0.20
  • TNYA -0.03
  • Stochastic Oscillator
  • DXYZ 7.52
  • TNYA 17.76

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Share on Social Networks: